Patents
Patents for C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
01/2015
01/29/2015WO2015010626A1 Therapeutically active compounds and use thereof
09/2014
09/25/2014WO2014146994A1 Urea derivatives and their use as fatty-acid binding protein (fabp) inhibitors
09/18/2014US20140275152 Compounds and uses thereof for the modulation of hemoglobin
07/2014
07/23/2014CN102264227B C5aR拮抗剂 C5aR antagonist
03/2014
03/13/2014WO2013190357A8 A process for the preparation of gabapentin
02/2014
02/19/2014CN103588706A Method for preparing lactames, comprising a photonitrosation step, followed by a beckmann transposition step
02/13/2014WO2014026143A1 Conjugated anti-microbial compounds and conjugated anti-cancer compounds and uses thereof
12/2013
12/27/2013WO2013190357A1 A process for the preparation of gabapentin
09/2013
09/24/2013US8541600 11-aza, 11-thia and 11-oxa sterol compounds and compositions
09/10/2013US8530469 Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
06/2013
06/06/2013DE19907945B4 Herstellung von sterisch gehinderten Aminethern Preparation of sterically hindered amine ethers
04/2013
04/16/2013CA2643170C Sterically hindered amine ethers as stabilizers against light, oxygen and/or heat
03/2013
03/26/2013US8404671 Heterosubstituted N-thiolated beta-lactam compounds and methods of use
03/12/2013CA2517077C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
02/2013
02/28/2013DE19964603B4 Sterisch gehinderte Aminether und deren Verwendung als Stabilisatoren für organisches Material Sterically hindered amine ethers and their use as stabilizers for organic material
08/2012
08/15/2012EP1615633B1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/07/2012US8236789 1-adamantyl azetidin-2-one derivatives and drugs containing same
07/2012
07/19/2012WO2012096813A1 Imidazole derivatives
07/04/2012EP2471918A1 Screening method
07/04/2012CN101619041B Method for synthesizing diketo nitrogen-containing compound and intermediates thereof
05/2012
05/08/2012US8173678 Kappa opioid receptor ligands
01/2012
01/04/2012CN101492421B Method for preparing trifluoro acetyl substituted ring amine and its derivative
12/2011
12/22/2011WO2011157227A1 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses
11/2011
11/15/2011US8058455 Compound signamycin, method for production thereof, and use thereof
10/2011
10/12/2011EP2374804A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/04/2011US8030491 Process and intermediate for preparation of donepezil
08/2011
08/23/2011US8003792 Bicyclic anilide spirolactam CGRP receptor antagonists
08/16/2011US7999120 from a liquid phase P comprising the target product X and constituents other than the target product X by cooling suspension crystallization in an indirect heat transferer; target product X in the process is acrylic acid
05/2011
05/10/2011CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides
05/04/2011CN102046604A Method for preparing lactames, comprising a photonitrosation step, followed by a beckmann transposition step
04/2011
04/07/2011WO2011040421A1 Screening method
03/2011
03/09/2011EP2291357A1 Method for preparing lactames, comprising a photonitrosation step, followed by a beckmann transposition step
01/2011
01/12/2011CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
12/2010
12/28/2010US7858795 or anticholinergic agents such as biphenyl-2-ylcarbamic acid 1-[2-({6-[(4-hydroxybenzylamino)methyl]pyridin-2-ylmethyl}carbamoyl)ethyl]piperidin-4-yl ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma
12/07/2010US7846920 Bactericides; bacteriostats; therapy for bacteria infections
11/2010
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
10/2010
10/27/2010CN1602290B Process for the synthesis of chirally pure beta -amino-alcohols
09/2010
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
08/2010
08/10/2010US7772392 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
05/2010
05/12/2010DE19918009B4 Fluorierte Cyclohexan-Derivate und flüssigkristallines Medium Fluorinated cyclohexane derivatives and liquid crystalline medium
03/2010
03/10/2010EP1494642B1 Organosilicon derivatives of aminohydroxybenzophenones and their use as UV-A filters in cosmetic preparations
01/2010
01/06/2010CN101619041A Method for synthesizing diketo nitrogen-containing compound and intermediates thereof
12/2009
12/23/2009WO2009153470A1 Method for preparing lactames, comprising a photonitrosation step, followed by a beckmann transposition step
12/22/2009CA2262435C Preparation of sterically hindered amine ethers
12/16/2009CN100569738C Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
11/2009
11/12/2009US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/11/2009EP2116529A1 Process for production of amide or lactam
08/2009
08/25/2009US7579339 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/05/2009CN100522941C Preparation of dithiol derivatives
07/2009
07/29/2009CN101492421A Method for preparing trifluoro acetyl substituted ring amine and its derivative
07/07/2009US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
06/2009
06/23/2009US7550484 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
04/2009
04/01/2009CN100473654C S type 4-substituted hydroxypyranoindolidine compound and derivatives and preparation thereof
03/2009
03/04/2009EP0869974B1 Compounds with growth hormone releasing properties
12/2008
12/16/2008US7465752 Peroxisome Proliferator Activated Receptors modulators; ethyl (R,S)-2-(4-trifluoromethylphenyl)oxypent-4-enoate; dyslipidemia, atherosclerosis and diabetes
10/2008
10/23/2008DE102008001262A1 Kontinuierliches Verfahren zur Herstellung von Alkyleniminen A continuous process for the production of alkyleneimines
10/08/2008CN100424076C Organosilicone derivatives of amino hydroxybenzophenones and their use as UV-A filters in cosmetic preparations
09/2008
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/03/2008CN100415716C 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/2008
08/28/2008WO2008083967A3 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
07/2008
07/17/2008WO2008084671A1 Process for producing 1-substituted-2-pyridone-3-carboxylic acid derivative
07/17/2008CA2674291A1 New process
07/10/2008WO2008081726A1 Process for production of amide or lactam
07/03/2008US20080161354 Stable s-nitrosothiols, method of synthesis and use
06/2008
06/24/2008US7390790 Antilipemic agents; anticholesterol agents, for example, 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid
06/17/2008US7388102 photostable; protecting human hair and/or skin against damage in which UVA irradiation plays a role or is implicated
04/2008
04/30/2008CN100384826C Preparation of sterically hindered amine ethers
04/23/2008CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
03/2008
03/18/2008CA2237279C Liquid polyfunctional additives
03/05/2008CN100372840C Intermediate for the preparation of epimino
02/2008
02/27/2008CN101130514A Intermediate for the preparation of epimino
01/2008
01/17/2008WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
01/17/2008US20080015169 Amino-methyl substituted tetracycline compounds
01/02/2008EP1871741A2 Substituted azetidinones
12/2007
12/18/2007CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
11/2007
11/21/2007CN100349872C Method for producing amine derivative
11/08/2007US20070259871 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
10/2007
10/18/2007US20070244122 Derivatives of sulindac, use thereof and preparation thereof
10/04/2007DE102006014335A1 Verdichtung von Sauerstoff Compression of oxygen
09/2007
09/27/2007US20070225331 4,4-Disubstituted piperidines, and methods of use thereof
09/18/2007CA2220533C 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
09/06/2007US20070208175 Condensing cyclohexanone with cyanoacetamide and reacting 2-cyclohexylidene-2-cyanoacetamide formed with malonate to form 3-cyano-5-carboxy-2,4-dioxo-3-azaspiro[5,5]undecane (claimed as an intermediate); hydrolysis, decarboxylation and further hydrolysis to form 3,3-pentamethyleneglutaramic acid
06/2007
06/06/2007CN1319936C Tertiary alkanolamine containing tensioactive alkyl group
04/2007
04/26/2007WO2006108039A3 Substituted azetidinones
04/11/2007EP0885180B1 Stabilized monomer composition
03/2007
03/29/2007US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/08/2007DE102005037418B3 New acyllactam compounds useful to increase the molecular weight of polycondensation products such as polyester or polyamide compounds
02/2007
02/20/2007US7179907 3-amino-2-oxo-azetidin-1-yl) acetic acid derivatives with anti-PBP2a activity; providing a monobactam core alkyne,reacting monobactam alkyne under conditions that promote cyclotrimerization, performing a Diels-Alder reaction between the cyclotrimerization product of b) and a diene reactant
02/13/2007US7176194 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
02/13/2007US7176193 Antilipemic agents; therapy for insulin resistance
02/06/2007US7173051 Inhibitors of cathepsin S
12/2006
12/26/2006US7153946 Molecular conjugates for use in treatment of cancer
10/2006
10/17/2006US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
10/12/2006CA2648522A1 Substituted azetidinones
08/2006
08/23/2006CN1821226A Antipicornaviral compounds, their preparation and use
06/2006
06/07/2006CN1781910A Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
05/2006
05/31/2006EP1660456A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
05/24/2006CN1777423A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
05/17/2006CN1772739A Bronsted acid room temperature ionic liquid with N-protonated lactem as cationic group and its prepn
04/2006
04/13/2006DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers
1 2 3 4 5